NCT06979037 Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
| NCT ID | NCT06979037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of University of South China |
| Condition | Diabetic Ulcers |
| Study Type | OBSERVATIONAL |
| Enrollment | 712 participants |
| Start Date | 2024-05-16 |
| Primary Completion | 2027-05-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 712 participants in total. It began in 2024-05-16 with a primary completion date of 2027-05-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial involves collecting peripheral blood, ulcer tissue, and fecal samples from diabetic ulcer patients for bioinformatics analysis to screen genetic markers significantly associated with ulcer risk and healing differences. Furthermore, multi-omics data will be integrated to establish a diabetic ulcer risk prediction model. Based on key single nucleotide polymorphisms and their regulatory pathways, potential new drug targets for promoting healing will be explored, providing a genetic basis for personalized treatment.
Eligibility Criteria
Inclusion Criteria: * 1\) Subjects who voluntarily participate in this clinical study and sign informed consent; * 2\) Patients with type 2 diabetes and diabetic ulcers; * 3\) Disease duration ≥ 10 years or age ≥ 55 years at enrollment; * 4\) Inpatient or outpatient who can be monitored by the same investigating team throughout the duration of the study. Exclusion Criteria: * 1\) Severe vascular occlusion or impairment; * 2\) Patients with congenital heart disease, aortic dissection, or other severe cardiovascular diseases; * 3\) Patients with ulcers caused by factors other than diabetes; * 4\) Patients with severe liver and kidney dysfunction or serious neurological impairment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06979037 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Ulcers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06979037 currently recruiting?
Yes, NCT06979037 is actively recruiting participants. Contact the research team at zhoujiecan@fsyy.usc.edu.cn for enrollment information.
Where is the NCT06979037 trial being conducted?
This trial is being conducted at Hengyang, China.
Who is sponsoring the NCT06979037 clinical trial?
NCT06979037 is sponsored by The First Affiliated Hospital of University of South China. The trial plans to enroll 712 participants.